Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06922526Recruiting

Pacemaker-related Tricuspid Regurgitation Progression and Long-term Outcomes

Role: lead

NCT06170307Completed

Left Atrial Function of COVID-19-recovered Patients During the Surge of Omicron Variants

Role: lead

NCT06199609Completed

Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula

Role: lead

NCT06192173Completed

Patent Foramen Ovale Closure in Migraine

Role: lead

NCT06196086Recruiting

Myocardial Stiffness Evaluation in Patients With Heart Failure With Preserved Ejection Fraction

Role: lead

All 5 trials loaded